Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;9(4):376-382.
doi: 10.1002/osp4.652. eCollection 2023 Aug.

Health state utilities associated with hyperphagia: Data for use in cost-utility models

Affiliations

Health state utilities associated with hyperphagia: Data for use in cost-utility models

Timothy A Howell et al. Obes Sci Pract. .

Abstract

Objective: Rare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperphagia. This study estimated utilities associated with various hyperphagia severity levels.

Methods: Four health state vignettes were developed using published literature and clinician input to represent various severity levels of hyperphagia. Utilities were estimated for these health states in a time trade-off elicitation study in a UK general population sample.

Results: In total, 215 participants completed interviews (39.5% male; mean age 39.1 years). Mean (SD) utilities were 0.98 (0.02) for no hyperphagia, 0.91 (0.10) for mild hyperphagia, 0.70 (0.30) for moderate hyperphagia, and 0.22 (0.59) for severe hyperphagia. Mean (SD) disutilities were -0.08 (0.10) for mild, -0.28 (0.30) for moderate, and -0.77 (0.58) for severe hyperphagia.

Conclusions: These data show increasing severity of hyperphagia is associated with decreased utility. Utilities associated with severe hyperphagia are similar to those of other health conditions severely impacting quality of life (QoL). These findings highlight that treatments addressing substantial QoL impacts of severe hyperphagia are needed. Utilities estimated here may be useful in cost-utility models of treatments for rare genetic diseases of obesity.

Keywords: health state utilities; hyperphagia; obesity; time trade‐off.

PubMed Disclaimer

Conflict of interest statement

Louis S. Matza and Timothy A. Howell are employed by Evidera, a company that received funding from Rhythm Pharmaceuticals, Inc., for time spent on this research. Ethan Lazarus received payment or honoraria for lectures, speaker bureaus, advisory boards or educational events for Novo Nordisk, Currax Pharmaceuticals, Nestle Health Services, and the Obesity Medicine Association; and serves as president of the Obesity Medicine Association and a delegate of the American Medical Association. Usha G. Mallya is an employee of Rhythm Pharmaceuticals, Inc. As an employee, they receive stocks or stock options. Anthony P. Goldstone has been principal investigator for clinical trials sponsored by Rhythm Pharmaceuticals, Inc.; a member of the Data Safety and Monitoring Board for clinical trials for and received speaker honorarium from Novo Nordisk; and a consultant or member of medical advisory board for Millendo Therapeutics, Soleno Therapeutics, Helsinn Healthcare S.A., Evidera, Rhythm Pharmaceuticals, Inc., and Radius Health. W. Scott Butsch has served as a consultant or member of clinical and education advisory boards for Novo Nordisk; Rhythm Pharmaceuticals, Inc.; and Merck.

Figures

FIGURE 1
FIGURE 1
Health state utilities and disutilities. Mean (95% confidence interval) utility and disutility values are reported for the various levels of hyperphagia. Severity levels are as follows: A, no hyperphagia; B, mild hyperphagia; C, moderate hyperphagia; D, severe hyperphagia. Disutility scores were derived as the utility difference between health state B, C or D and health state A.

References

    1. Heymsfield SB, Avena NM, Baier L, et al. Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia. Obesity. 2014;22(suppl 1):S1‐S17. 10.1002/oby.20646 - DOI - PMC - PubMed
    1. Huvenne H, Dubern B, Clement K, Poitou C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obes Facts. 2016;9(3):158‐173. 10.1159/000445061 - DOI - PMC - PubMed
    1. Lavelle TA, Crossnohere NL, Bridges JFP. Quantifying the burden of hyperphagia in Prader‐Willi syndrome using quality‐adjusted life‐years. Clin Therapeut. 2021;43(7):1164‐1178. 10.1016/j.clinthera.2021.05.013 - DOI - PubMed
    1. Brazier J, Ara R, Azzabi I, et al. Identification, review, and use of health state utilities in cost‐effectiveness models: an ISPOR Good Practices for Outcomes Research Task Force report. Value Health. 2019;22(3):267‐275. 10.1016/j.jval.2019.01.004 - DOI - PubMed
    1. Keating CL, Moodie ML, Richardson J, Swinburn BA. Utility‐based quality of life of overweight and obese adolescents. Value Health. 2011;14(5):752‐758. 10.1016/j.jval.2011.02.1181 - DOI - PubMed

LinkOut - more resources